2020 was another record year for Biovision with income of 10.8 million Swiss francs. This excellent result was reached, thanks to private individual donors and earmarked contributions from institutional partners, despite the major challenges faced during the pandemic year 2020. Within the framework of our institutional partnership with the Swiss Agency for Development and Cooperation (SDC), we received a programme contribution of 1.165 million Swiss francs. A further increase was reported in supporter membership fees, which came to 1.1 million Swiss francs. Biovision also received bequests totalling 0.87 million Swiss francs in 2020. We would like to take this opportunity to express our sincere thanks for the trust placed in us by our loyal donors, whose contributions have always been the bedrock for Biovision, allowing us to realise the Foundation’s mission. We would also like to say a big thank you to our institutional partners and the SDC, whose project and programme contributions in 2020, once again, enabled us to make a sustainable commitment to our priority themes – in Switzerland, globally and with our project partners in sub-Saharan Africa.

Project expenditure

Due to the global Corona pandemic, Biovision was able to invest significantly less in projects in 2020 than planned, at around 7.1 million Swiss francs (6 % less than the previous year). The under-spending is mainly explained by development project delays, the cancellation, postponement or virtually conducted conferences and meetings in the area of policy dialogue and advocacy, as well as cancelled, postponed or reduced awareness-raising activities in the Swiss programme. Fortunately, for all ongoing projects in sub-Saharan Africa, the financing, and the operation of the projects with our local project-partners was secured, despite the pandemic.

Fundraising and general advertising expenditure

Collective expenditure is calculated in accordance with the current ZEWO regulations. The spending on fundraising and advertising amounted to around 1.5 million Swiss francs, which represents 16 % of Biovision’s overall expenses. This expenditure allows Biovision to obtain diversified financing and to benefit from a strong donor base.

Administrative Expenses

Administrative expenses amounted to around 1.0 million Swiss francs, slightly lower than in the previous year at 10.7% of Biovision’s overall expenses.


In 2020, Biovision recorded a positive variance following fund adjustment with a surplus of 1.18 million Swiss francs. The positive balance will be allocated to organisational capital; of this, 0.98 million Swiss francs will be apportioned to tied capital for projects and 200,000 Swiss francs to free capital.

Performance indicators 2020:


As a ZEWO-certified foundation, Biovision fulfills the accounting regulations for non-profit organisations in Switzerland. Furthermore our financial accounting adheres to the Swiss GAAP FER 21 principles for non-profit organizations and is audited by external auditors.

In its fundraising, Biovision is committed to the ethical guidelines of "Swissfundraising".

Donations to Biovision are tax-deductable in Switzerland, and maybe in other countries depending on tax laws. Biovision has obtained a legal opinion that it is equivalent to a Section 501(c)(3) public charity in the US.